Form 4: CME Group Executive's Performance Share Vesting

CME Group Senior Managing Director Derek Sammann received performance shares and sold a portion for tax obligations.

Summary

• Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc. (CME), reported changes in his beneficial ownership.
• On March 15, 2026, Sammann acquired 8,256 shares of Common Stock Class A at a price of $311.4 per share.
• This acquisition represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan.
• The number of vested shares was determined by the company's achievement of total shareholder return relative to the S&P 500 over a three-year period from January 1, 2023, through December 31, 2025.
• Concurrently, Sammann disposed of 3,627 shares of Common Stock Class A at the same price of $311.4 per share to fulfill tax withholding obligations related to the performance share award.
• Following these transactions, Sammann directly owns 13,312 shares of Common Stock Class A.
• Additionally, Sammann indirectly beneficially owns 11,028 shares through a Trust and 7,022 shares through his Spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as the vesting of performance shares confirms CME Group's strong performance against a key market benchmark over the past three years, indicating effective executive incentive alignment.

Positives

• The vesting of performance shares indicates that CME Group met its total shareholder return targets relative to the S&P 500 over the three-year performance period (January 1, 2023, to December 31, 2025), reflecting strong company performance.

Negatives

• A portion of the vested shares (3,627 shares) was sold to cover tax withholding obligations, resulting in a net decrease in direct beneficial ownership from the initial vested amount.

Future Outlook

This filing primarily reports past performance and a routine executive compensation event, not providing specific forward-looking statements or guidance for the company's future operations or financial performance.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance metrics like Total Shareholder Return (TSR) relative to an index (S&P 500) is a common practice in the financial services industry, aligning management incentives with shareholder interests. The successful vesting of these shares suggests CME Group's performance was competitive within its market segment during the specified period.

Comparison to Industry Standards

• The use of performance shares tied to relative TSR against the S&P 500 is a standard practice for executive compensation in large-cap financial companies, similar to structures seen at peers like Intercontinental Exchange (ICE) or Nasdaq (NDAQ).
• The subsequent sale of shares to cover tax obligations upon vesting is also a routine and expected event for executives receiving equity awards across the industry.

Stakeholder Impact

• Shareholders: The vesting of performance shares based on relative TSR suggests that shareholder value creation targets were met, which is generally positive for existing shareholders.
• Employees: The compensation structure reflects a commitment to performance-based incentives, potentially influencing employee motivation and retention.

Key Dates

Keywords

CME Group, CME, Derek Sammann, Form 4, Insider Transaction, Performance Shares, Stock Vesting, Executive Compensation, Beneficial Ownership, Commodities Markets